Monitoring of inflammation in patients on dialysis: forewarned is forearmed (Q37848040)

24 August 2017

1 reference

title

Monitoring of inflammation in patients on dialysis: forewarned is forearmed (English)

1 reference

24 August 2017

0 references

0 references

0 references

2

1 reference

24 August 2017

4

1 reference

24 August 2017

Friedo W Dekker

3

0 references

Christiaan Lucas Meuwese

series ordinal

1

object named as

Christiaan L Meuwese

1 reference

PubMed ID

21358695

24 August 2017

language of work or name

English

0 references

publication date

1 March 2011

1 reference

Nature Reviews Nephrology

24 August 2017

1 reference

24 August 2017

7

1 reference

24 August 2017

166-176

1 reference

24 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2011.2

24 August 2017

0 references

cites work

Chronic kidney disease as cause of cardiovascular morbidity and mortality

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Cardiovascular and noncardiovascular mortality among patients starting dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Immunologic function and survival in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Cytokine production in haemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Cytokine dysregulation in chronic kidney disease: how can we treat it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Initiation of acute phase response and synthesis of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Systemic cytokine response after major surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

C-reactive protein: a critical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Genetically elevated C-reactive protein and ischemic vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

C-Reactive protein haplotype predicts serum C-reactive protein levels but not cardiovascular disease risk in a dialysis cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Fluctuating Inflammatory Markers in Patients With Stable Ischemic Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Refinement of the association of serum C-reactive protein concentration and coronary heart disease risk by correction for within-subject variation over time: the MONICA Augsburg studies, 1984 and 1987.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Epidemiology, heritability, and genetic linkage of C-reactive protein in African Americans (from the Jackson Heart Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Race and gender differences in C-reactive protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Intra-individual variability of high-sensitivity C-reactive protein: age-related variations over time in Japanese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Gender differences in chronic kidney disease: underpinnings and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. The HEMO Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

C-reactive protein in patients on chronic hemodialysis with different techniques and different membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

DNA variants, plasma levels and variability of C-reactive protein in myocardial infarction survivors: results from the AIRGENE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Significance of high C-reactive protein levels in pre-dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Inflammation and cardiovascular risk in dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Increased C-reactive protein following hemodialysis predicts cardiac hypertrophy in chronic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Interleukin-6 is a predictor of mortality in stable hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Elevated cardiac troponin T predicts cardiovascular events in asymptomatic continuous ambulatory peritoneal dialysis patients without a history of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Survival analysis: time-dependent effects and time-varying risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Variability in calcium, phosphorus, and parathyroid hormone in patients on hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Hemoglobin variability and mortality in ESRD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Homocysteine and C-reactive protein levels in haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Coordinated increase in albumin, fibrinogen, and muscle protein synthesis during hemodialysis: role of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Inflammation in end-stage renal disease--what have we learned in 10 years?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Statistical methods for the assessment of prognostic biomarkers(part II): calibration and re-classification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Statistical methods for the assessment of prognostic biomarkers (Part I): discrimination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Captopril directly inhibits matrix metalloproteinase-2 activity in continuous ambulatory peritoneal dialysis therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

CCR5 deletion protects against inflammation-associated mortality in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Cytokines as therapeutic targets: advances and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

The pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Exploring Inflammation in Hemodialysis Patients: Persistent and Superimposed Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

The variability and accurate assessment of microinflammation in haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Dissecting Inflammation in ESRD: Do Cytokines and C-Reactive Protein Have a Complementary Prognostic Value for Mortality in Dialysis Patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Inflammation Markers, Adhesion Molecules, and All-Cause and Cardiovascular Mortality in Patients with ESRD: Searching for the Best Risk Marker by Multivariate Modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Inflammation and outcome in end-stage renal failure: Does female gender constitute a survival advantage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

31 March 2020

12 December 2020

Effect of an Increase in C-Reactive Protein Level during a Hemodialysis Session on Mortality

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Blood-membrane interaction in hemodialysis leads to increased cytokine production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

C-reactive protein and mortality in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Low-grade inflammation in chronic kidney disease patients before the start of renal replacement therapy: sources and consequences.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Nutritional status and postoperative cytokine response in colorectal cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Intra-individual variation of plasma adipokine levels and utility of single measurement of these biomarkers in population-based studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Day-to-day variation in plasma interleukin-6 concentrations in older adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Intercurrent clinical events are predictive of plasma C-reactive protein levels in hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

C-reactive protein levels in patients on maintenance hemodialysis: reliability and reflection on the utility of single measurements

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Strict volume control and longitudinal changes in cardiac biomarker levels in hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Pentraxin 3 is elevated in haemodialysis patients and is associated with cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Comparison of serum albumin, C-reactive protein and carotid atherosclerosis as predictors of 10-year mortality in hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Inflammation, Residual Kidney Function, and Cardiac Hypertrophy Are Interrelated and Combine Adversely to Enhance Mortality and Cardiovascular Death Risk of Peritoneal Dialysis Patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

The prognostic impact of fluctuating levels of C-reactive protein in Brazilian haemodialysis patients: a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

The effect of single and repeatedly high concentrations of C-reactive protein on cardiovascular and non-cardiovascular mortality in patients starting with dialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor- are similarly associated with survival in haemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Persistent elevation of C-reactive protein may predict cardiac hypertrophy and dysfunction in patients maintained on hemodialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Changes in serum fetuin-A and inflammatory markers levels in end-stage renal disease (ESRD): effect of a single session haemodialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Reduced expression of systemic proinflammatory cytokines after off-pump versus conventional coronary artery bypass grafting

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Variations in C-reactive protein during a single haemodialysis session do not associate with mortality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

C-reactive protein and cardiovascular disease in peritoneal dialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

Inflammation enhances cardiovascular risk and mortality in hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

TNF-α levels are not increased in inflamed patients carrying the CCR5 deletion 32

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

The effect of etanercept on suppression of the systemic inflammatory response in chronic hemodialysis patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.2

The time course of serum C-reactive protein is more predictive of mortality than its baseline level in peritoneal dialysis patients.

31 March 2020

1 reference

12 December 2020

Plasma cytokine levels predict mortality in patients with acute renal failure.

1 reference

12 December 2020

Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction

1 reference

12 December 2020

Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications.

1 reference

12 December 2020

Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults.

1 reference

12 December 2020

Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2011.2

1 reference

24 August 2017

1 reference

PubMed ID

21358695